What is it about?
Intravenous immunoglobulins with their broad immunomodulatory mechanism of action could be ideally effective in different forms of immune dysregulated intractable epilepsies.
Featured Image
Why is it important?
A total of 11 prospective studies were identified in the literature demonstrating a favorable effect of this therapeutic option in children with drug-resistant epilepsy and in cases of encephalitis. No serious adverse effects were reported.
Perspectives
In cooperation with my young colleagues I was very happy writing this article because I use often immunoglobulins in my daily clinical practice.
Athanasios Evangeliou
Aristotle University of Thessaloniki
Read the Original
This page is a summary of: Clinical Applications of Intravenous Immunoglobulins in Child Neurology, Current Pharmaceutical Biotechnology, November 2017, Bentham Science Publishers,
DOI: 10.2174/1389201018666170915123700.
You can read the full text:
Contributors
The following have contributed to this page
